| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -4,544 | -3,000 |
| Effect of changes in exchange rate on cash and cash equivalents | -68 | -58 |
| Net (decrease) increase in cash and cash equivalents | -138,776 | -134,019 |
| Cash and cash equivalents at beginning of period | 354,349 | - |
| Cash and cash equivalents at end of period | 215,573 | - |
BioAge Labs, Inc. (BIOA)
BioAge Labs, Inc. (BIOA)